{
    "nctId": "NCT02123862",
    "briefTitle": "Cultured Circulating Tumor Cells in Prostate and Other Cancers",
    "officialTitle": "Cultured Circulating Tumor Cells - Development of a Novel Platform for Drug Discovery and in Vitro Chemosensitivity Testing in Prostate and Other Cancers",
    "overallStatus": "UNKNOWN",
    "conditions": "Prostate Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 220,
    "primaryOutcomeMeasure": "Evaluate novel CTC assay method as a predictive tool for prostate, breast and colorectal cancers.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of prostate cancer, breast cancer, or other cancer, OR have no cancer. All participants will be having blood drawn at Comprehensive Cancer Centers of Nevada as part of their routine care.\n* 18 years of age or older.\n* All participants must be informed of the investigational nature of this study, and must sign and give written informed consent in accordance with institutional and FDA guidelines.\n\nExclusion Criteria:\n\n-",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}